# Testopel

NDC: 66887-004
Generic name: testosterone
Labeler / Manufacturer: Endo USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: PELLET
Routes: SUBCUTANEOUS
Marketing started: 20141031

FDA application: ANDA080911

## Active ingredients

- TESTOSTERONE: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66887-004"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66887-004
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03b9c0b1-5884-11e4-8ed6-0800200c9a66